Normalizing Breast Cancer Conversations with Michael Cox

What this episode covers

In the U.S today, Black women are more likely to be diagnosed with breast cancer at a younger age, in later stages, with more aggressive types and have a lower 5-year survival rate. These disparities aren’t just caused by health issues but also by social injustice—unequal access to health care, a lack of diversity in medical research and services, unaddressed cultural barriers and more. Michael Cox joins the show today to talk about these risks and normalize conversations about breast cancer. Special Guest: Michael Cox. Sponsored By: Amgen Oncology : At Amgen, we are committed to the relentless pursuit of breakthroughs for cancer patients and their families. We have a deep and diverse pipeline of cutting-edge therapeutic approaches that aim to improve outcomes. Amgen has been pursuing novel treatment approaches for more than 40 years. We never stop looking toward the next frontier of innovation to bring the greatest potential benefit to patients. Merck : Merck is on a mission is to deliver innovations that extend and improve the lives of people with cancer.

Distinct summary based on available episode metadata or transcript content.